Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CRB1-Related Maculopathy With Cystoid Macular Edema.
Wolfson Y, Applegate CD, Strauss RW, Han IC, Scholl HP. Wolfson Y, et al. JAMA Ophthalmol. 2015 Nov;133(11):1357-60. doi: 10.1001/jamaophthalmol.2015.2814. JAMA Ophthalmol. 2015. PMID: 26312378 No abstract available.
Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group. Schönbach EM, et al. Among authors: wolfson y. JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162. JAMA Ophthalmol. 2017. PMID: 28542693 Free PMC article.
Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.
Schönbach EM, Strauss RW, Muñoz B, Wolfson Y, Ibrahim MA, Birch DG, Zrenner E, Sunness JS, Ip MS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group. Schönbach EM, et al. Among authors: wolfson y. JAMA Ophthalmol. 2020 Jul 1;138(7):772-779. doi: 10.1001/jamaophthalmol.2020.1735. JAMA Ophthalmol. 2020. PMID: 32463436 Free PMC article.
The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).
Strauss RW, Muñoz B, Ahmed MI, Bittencourt M, Schönbach EM, Michaelides M, Birch D, Zrenner E, Ervin AM, Charbel Issa P, Kong J, Wolfson Y, Shah M, Bagheri S, West S, Scholl HPN; for the ProgStar-4 Study Group. Strauss RW, et al. Among authors: wolfson y. Ophthalmic Res. 2018;60(3):185-194. doi: 10.1159/000491791. Epub 2018 Aug 15. Ophthalmic Res. 2018. PMID: 30110705
23 results